Adherence affects response to baricitinib in the BANDIT trial in new-onset type 1 diabetes

被引：0
|
作者：
Kay, T. [1 ]
机构：
[1] St Vincents Inst Med Res, Fitzroy, Vic, Australia
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
基金：
澳大利亚国家健康与医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
684
引用
收藏
页码：S347 / S347
页数：1
相关论文
共 50 条
  • [1] Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes
    Waibel, Michaela
    Wentworth, John M.
    So, Michelle
    Couper, Jennifer J.
    Cameron, Fergus J.
    Macisaac, Richard J.
    Atlas, Gabby
    Gorelik, Alexandra
    Litwak, Sara
    Sanz-Villanueva, Laura
    Trivedi, Prerak
    Ahmed, Simi
    Martin, Francis J.
    Doyle, Madeleine E.
    Harbison, Jessica E.
    Hall, Candice
    Krishnamurthy, Balasubramanian
    Colman, Peter G.
    Harrison, Leonard C.
    Thomas, Helen E.
    Kay, Thomas W. H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (23): : 2140 - 2150
  • [2] Immunotherapy on trial for new-onset type 1 diabetes
    Faustman, Denise L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (18): : 1956 - 1958
  • [3] Ergocalciferol in New-onset Type 1 Diabetes: A Randomized Controlled Trial
    Nwosu, Benjamin Udoka
    Parajuli, Sadichchha
    Jasmin, Gabrielle
    Fleshman, Jody
    Sharma, Rohit B.
    Alonso, Laura C.
    Lee, Austin F.
    Barton, Bruce A.
    JOURNAL OF THE ENDOCRINE SOCIETY, 2022, 6 (01)
  • [4] Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)—study protocol for a phase 2, randomized, placebo controlled trial
    M. Waibel
    H. E. Thomas
    J. M. Wentworth
    J. J. Couper
    R. J. MacIsaac
    F. J. Cameron
    M. So
    B. Krishnamurthy
    M. C. Doyle
    T. W. Kay
    Trials, 23
  • [5] Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)-study protocol for a phase 2, randomized, placebo controlled trial
    Waibel, M.
    Thomas, H. E.
    Wentworth, J. M.
    Couper, J. J.
    MacIsaac, R. J.
    Cameron, F. J.
    So, M.
    Krishnamurthy, B.
    Doyle, M. C.
    Kay, T. W.
    TRIALS, 2022, 23 (01)
  • [6] Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial
    Lars Krogvold
    Ida Maria Mynarek
    Erica Ponzi
    Freja Barrett Mørk
    Trine Witzner Hessel
    Trine Roald
    Nina Lindblom
    Jacob Westman
    Peter Barker
    Heikki Hyöty
    Johnny Ludvigsson
    Kristian F. Hanssen
    Jesper Johannesen
    Knut Dahl-Jørgensen
    Nature Medicine, 2023, 29 : 2902 - 2908
  • [7] Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial
    Krogvold, Lars
    Mynarek, Ida Maria
    Ponzi, Erica
    Mork, Freja Barrett
    Hessel, Trine Witzner
    Roald, Trine
    Lindblom, Nina
    Westman, Jacob
    Barker, Peter
    Hyoety, Heikki
    Ludvigsson, Johnny
    Hanssen, Kristian F.
    Johannesen, Jesper
    Dahl-Jorgensen, Knut
    NATURE MEDICINE, 2023, 29 (11) : 2902 - 2908
  • [8] Characteristics of type 1 and type 2 new-onset diabetes in children
    Burghen, GA
    Christensen, ML
    Kritchevsky, SB
    West, B
    Rose, SR
    Faulkner, MS
    Parnell, DI
    Broome, DC
    Danish, RK
    Valesquez-Mieyer, PA
    Lustig, RH
    PEDIATRIC RESEARCH, 2000, 47 (04) : 126A - 126A
  • [9] Rash in a Patient With New-Onset Type 1 Diabetes Mellitus
    Wahba, Amr
    Ogunsakin, Amie
    AACE CLINICAL CASE REPORTS, 2023, 9 (05): : 178 - 179
  • [10] Delayed referral and DKA in new-onset Type 1 diabetes
    White, Mary
    Manski-Nankervis, Jo-Anne
    JOURNAL OF PEDIATRICS, 2022, 244 : 251 - 251
12345